Benefits of Orphan Designation in EU and USA1 May 2026 11:35
In order to achieve above status NFX had to show medical plausability,scientific rationale,prevalence.justification of significant benefit or why other methods are not satisfactory.The benefits of such status give a company significant taxation and other commercial benefits.
Detractors complaints that Dan and Co have not achieved much over the years is plainly wrong as the above are worthy goals which investors were waiting for and willing to pay for at much higher prices than today.
Everything that prospective partners need has so far been delivered and I have confidence that naysayers will be proved wrong in due course.